Armanda Casrouge

Title: Armanda Casrouge: Innovator in Immunology

Introduction

Armanda Casrouge is a notable inventor based in Draveil, France. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, his work focuses on methods for treating infections and enhancing immune responses.

Latest Patents

Casrouge's latest patents include groundbreaking methods for using sIP-10, CD26 inhibitors, and CXCR3 levels in samples to assess the clearance of infections and responses to interferon therapy. His inventions relate to the treatment of infections, diseases, or conditions using CD26 (DPIV) inhibitors. Additionally, he has developed an antibody that binds to the IP-10 protein, along with a method for monitoring the necessity of administering a CD26 inhibitor to patients by evaluating levels of sIP-10, CD26 activity, and CXCR3 cells in samples. Another significant patent involves altered major histocompatibility complex (MHC) determinants, which can be associated with antigens to elicit immune responses, potentially aiding in the treatment of diseases such as AIDS, multiple sclerosis, and lupus erythematosus.

Career Highlights

Throughout his career, Casrouge has worked with prestigious institutions such as the Institut Pasteur and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing our understanding of immune responses and treatment methodologies.

Collaborations

Some of his notable coworkers include Jean-Pierre Abastado and Estelle Mottez, who have contributed to his research endeavors.

Conclusion

Armanda Casrouge's innovative work in immunology and his patents reflect his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various diseases and improve patient outcomes.